Total reversibility testing as indicator of the clinical efficacy of formoterol in COPDMOLIMARD, Mathieu; BOURCEREAU, Jacques; LE GROS, Vincent et al.Respiratory medicine. 2005, Vol 99, Num 6, pp 695-702, issn 0954-6111, 8 p.Article

The degradation of salbutamol in ethanolic solutionsCOPE, Mike; BAUTISTA-PARRA, Fernando.Journal of pharmaceutical and biomedical analysis. 2010, Vol 52, Num 2, pp 210-215, issn 0731-7085, 6 p.Article

In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devicesBARRY, P. W; O'CALLAGHAN, C.The European respiratory journal. 1997, Vol 10, Num 6, pp 1345-1348, issn 0903-1936Article

Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systemsCORRIGAN, Deirdre O; CORRIGAN, Owen I; HEALY, Anne Marie et al.International journal of pharmaceutics. 2004, Vol 273, Num 1-2, pp 171-182, issn 0378-5173, 12 p.Article

Supercritical and near-critical carbon dioxide assisted low-temperature bubble dryingSIEVERS, R. E; MILEWSKI, P. D; SELLERS, S. P et al.Industrial & engineering chemistry research. 2000, Vol 39, Num 12, pp 4831-4836, issn 0888-5885Conference Paper

Introduction of a single isomer beta agonistRAU, J. L.Respiratory care. 2000, Vol 45, Num 8, pp 962-966, issn 0020-1324Article

Estimation of drug concentrations in plasma from urinary excretion data : an illustration based on salbutamolBOULTON, D. W; FAWCETT, J. P.European journal of clinical pharmacology. 1998, Vol 53, Num 5, pp 373-374, issn 0031-6970Article

Magicscope containsCOLES, T.Manufacturing chemist (London. 1981). 1998, Vol 69, Num 7, pp 32-33, issn 0262-4230Article

On the relationship between drug and carrier deposition from dry powder inhalers in vitroSRICHANA, T; MARTIN, G. P; MARRIOTT, C et al.International journal of pharmaceutics. 1998, Vol 167, Num 1-2, pp 13-23, issn 0378-5173Article

Development and Validation of a Stability-Indicating High-Performance Liquid Chromatography Method for the Simultaneous Determination of Albuterol, Budesonide, and Ipratropium Bromide in Compounded Nebulizer SolutionsBLEWETT, Anthony J; VARMA, Deepti; GILLES, Tiffany et al.Journal of AOAC International. 2011, Vol 94, Num 1, pp 110-117, issn 1060-3271, 8 p.Article

Salbutamol intake and substrate oxidation during submaximal exerciseARLETTAZ, A; LE PANSE, B; PORTIER, H et al.European journal of applied physiology (Print). 2009, Vol 105, Num 2, pp 207-213, issn 1439-6319, 7 p.Article

Strength training and albuterol in facioscapulohumeral muscular dystrophyVAN DER KOOI, E. L; VOGELS, O. J. M; VAN ASSELDONK, R. J. G. P et al.Neurology. 2004, Vol 63, Num 4, pp 702-708, issn 0028-3878, 7 p.Article

Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterolDHAND, R; GOODE, M; REID, R et al.American journal of respiratory and critical care medicine. 1999, Vol 160, Num 4, pp 1136-1141, issn 1073-449XArticle

Evaluation of the adhesion properties of salbutamol sulphate to inhaler materialsPODCZECK, F.Pharmaceutical research. 1998, Vol 15, Num 5, pp 806-808, issn 0724-8741Article

Variations in predicted regional lung deposition of salbutamol sulphate between 19 nebulizer typesFINLAY, W. H; STAPLETON, K. W; ZUBERBUHLER, P et al.Journal of aerosol medicine. 1998, Vol 11, Num 2, pp 65-80, issn 0894-2684Article

Development and evaluation of fast-dissolving film of salbutamol sulphateMASHRU, R. C; SUTARIYA, V. B; SANKALIA, M. G et al.Drug development and industrial pharmacy. 2005, Vol 31, Num 1, pp 25-34, issn 0363-9045, 10 p.Article

Contrasting properties of albuterol stereoisomersPAGE, C. P; MORLEY, J.Journal of allergy and clinical immunology. 1999, Vol 104, Num 2, pp S31-S41, issn 0091-6749, 2Article

Aerosol delivery from an active emission multi-single dose dry powder inhalerCONCESSIO, N. M; JÄGER-WALDAU, R; HICKEY, A. J et al.Particulate science and technology. 1997, Vol 15, Num 1, pp 51-63, issn 0272-6351Article

Tolerance to the bronchoprotective effect of β₂-agonists : Comparison of the enantiomers of salbutamol with racemic salbutamol and placeboCOCKCROFT, D. W; DAVIS, B. E; SWYSTUN, V. A et al.Journal of allergy and clinical immunology. 1999, Vol 103, Num 6, pp 1049-1053, issn 0091-6749Article

Clinical experience with levalbuterolNELSON, H. S.Journal of allergy and clinical immunology. 1999, Vol 104, Num 2, pp S77-S84, issn 0091-6749, 2Article

Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizerLIPWORTH, B. J; CLARK, D. J.British journal of clinical pharmacology. 1998, Vol 45, Num 2, pp 160-163, issn 0306-5251Article

Inertial sizing of aerosol inhaled during pediatric tidal breathing from an MDI with attached holding chamberFINLAY, W. H.International journal of pharmaceutics. 1998, Vol 168, Num 2, pp 147-152, issn 0378-5173Article

Effet du Salbutamol® pressurisé sur le bronchospasme induit par l'exercice en climat chaud du BéninMESSAN, F; LOUNANA, J; MEDELLI, J et al.Médecine d'Afrique noire. 2011, Vol 58, Num 2, pp 74-78, issn 0465-4668, 5 p.Article

Nitric Oxide Is Involved in the Response of the Isolated Intact and Epithelium-Denuded Rat Trachea to the β₂ Adrenergic Receptor Agonist SalbutamolMONTALVO, F; CANTRES-FONSECA, O; SANTOS, G et al.Respiration (Basel). 2010, Vol 80, Num 5, pp 426-432, issn 0025-7931, 7 p.Article

Rapid analysis of clenbuterol, salbutamol, procaterol, and fenoterol in pharmaceuticals and human urine by capillary electrophoresisSIRICHAI, Somsak; KHANATHARANA, Proespichaya.Talanta (Oxford). 2008, Vol 76, Num 5, pp 1194-1198, issn 0039-9140, 5 p.Article